Molecular mechanisms controlling the development of dopaminergic neurons.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 12948352)

Published in Semin Cell Dev Biol on June 01, 2003

Authors

John C Lin1, Arnon Rosenthal

Author Affiliations

1: Rinat Neuroscience Corp., Palo Alto, CA 94304, USA. jclin@rinatneuro.com

Articles by these authors

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell (2009) 3.46

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation (2004) 2.67

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci (2004) 2.38

Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci (2005) 2.06

Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J Neurosci (2006) 1.79

Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiol Dis (2004) 1.73

The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons. Nat Neurosci (2003) 1.66

Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene. Mol Cell Biol (2003) 1.53

Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U S A (2004) 1.47

Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development (2004) 1.34

Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain (2005) 1.20

TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology (2007) 1.16

Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome. Blood (2005) 1.16

Zinc finger protein too few controls the development of monoaminergic neurons. Nat Neurosci (2003) 1.15

Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice. J Neuroinflammation (2006) 0.97

Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates. PLoS One (2008) 0.92

C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol (2013) 0.92

A direct role of the homeodomain proteins Phox2a/2b in noradrenaline neurotransmitter identity determination. J Neurochem (2002) 0.91

Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice. J Neurosci (2009) 0.89

Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice. J Neuroimmune Pharmacol (2008) 0.85

Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice. Hum Mol Genet (2005) 0.79

Chronological age impacts immunotherapy and monocyte uptake independent of amyloid load. J Neuroimmune Pharmacol (2011) 0.75